14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
ACEP vs MRNO: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Murano Global Investments PLC (MRNO) is the stronger overall head-to-head candidate over ACEP (ACEP) in the Tradestie Institutional Equity Comparison Engine, winning 5–3 core matrix metrics and 4–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). ACEP carries a Unified Composite Score of 60.7/100 (BUY) at $19.79 (N/M Forward P/E, N/A operating margin), whereas MRNO carries 46.8/100 (HOLD) at $0.17 (N/M Forward P/E, -29.2% operating margin).
Composite vs. Pillar Nuance: While ACEP currently prints a higher short-term Unified Composite Score (60.7/100 BUY vs. MRNO 46.8/100 HOLD), MRNO captures the overall institutional head-to-head verdict (5–3 matrix metrics and 4–0 across the 6 pillars) due to superior fundamental profitability (-29.2% vs. N/A operating margin) and revenue trajectory (-14.9% vs. N/A YoY).
Technical & Structure Timing Caution: ACEP is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 45.5); meanwhile MRNO is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 35.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ACEP vs MRNO. Trailing 12-month operating profitability (ACEP N/A vs MRNO -29.2%) and valuation multiples (ACEP N/M vs MRNO N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Real Estate - Development value chain with $15.8M market capitalization and -29.2% operating margin.
OpEx & R&D Reinvestment69.1% of Rev ($788M)
90D Engineering Disclosures0 Published
Investor FAQ ACEP vs MRNO Key Questions & Quantitative Answers
As of Nov 16, 2026, Murano Global Investments PLC (MRNO) is the stronger overall head-to-head candidate over ACEP (ACEP) in the Tradestie Institutional Equity Comparison Engine, winning 5–3 core matrix metrics and 4–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). ACEP carries a Unified Composite Score of 60.7/100 (BUY) at $19.79 (N/M Forward P/E, N/A operating margin), whereas MRNO carries 46.8/100 (HOLD) at $0.17 (N/M Forward P/E, -29.2% operating margin). Composite vs. Pillar Nuance: While ACEP currently prints a higher short-term Unified Composite Score (60.7/100 BUY vs. MRNO 46.8/100 HOLD), MRNO captures the overall institutional head-to-head verdict (5–3 matrix metrics and 4–0 across the 6 pillars) due to superior fundamental profitability (-29.2% vs. N/A operating margin) and revenue trajectory (-14.9% vs. N/A YoY). Technical & Structure Timing Caution: ACEP is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 45.5); meanwhile MRNO is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 35.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
MRNO leads the Growth & Scale pillar: ACEP posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with MRNO at -14.9% YoY revenue growth and +0.0% YoY earnings growth on $1.14B TTM revenue (39.9% gross margin, -29.2% operating margin). On trailing 12-month operating scale, ACEP generates N/A in USD-normalized revenue versus $1.14B for MRNO. In operating R&D and SG&A reinvestment, ACEP deploys N/A (0 90-day corporate R&D disclosures) versus 69.1% of Rev ($788M) (0 disclosures) for MRNO.
ACEP and MRNO trade at balanced relative valuation multiples. ACEP trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas MRNO trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (-8.4% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ACEP (N/A ROE) versus MRNO (-7.5% ROE) capital efficiency.
In options market volatility and institutional positioning, ACEP carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.86β · 20% Vol realized risk). By comparison, MRNO carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.49β · 76% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.